Meet The New Era Of Big Health Industry, Media And Think Tank Drive 21 New "Health +" Platform Upgrade

On January 25, the first new year's activity of "2021 China's large health industry series activities" sponsored by the 21st century economic report under the guidance of Nanfang finance and economics group - "2021 China's big health industry cloud Summit (spring)" successfully concluded. From the national DRG and dip expert group, Shanghai Ruijin hospital industry experts, as well as AstraZeneca, 3M, cornerstone pharmaceutical, Aikang Guobin, tengshengbo medicine, new mileage hospital group and other enterprise executives, the new changes and new trends of the industry under the epidemic situation were discussed in depth.

In addition, in order to further cultivate the big health industry and embrace the new era of industrial development, the 21st century economic report officially announced the establishment of the 21st New Health Research Institute at the summit, and simultaneously released the first research project achievements - "digital reading 2020 China's big health industry" series reports.

As the finale of the summit, "China's big health industry in 2020" was finally unveiled.

Epidemic situation promotes the new era of big health industry

"The epidemic in 2020 is a disaster for the country and a disaster for the people. Through science and technology, we can quickly control the epidemic situation and realize our own shortcomings in the disaster. In the process of fighting the epidemic, we have also exposed our weaknesses and weaknesses - the construction of the public health system. " Chen Erzhen, vice president of Shanghai Ruijin Hospital, leader of the third batch of medical team of Shanghai aiding Hubei Province and member of Shanghai expert group on treatment of new crown pneumonia, pointed out in the dialogue.

As the first corporate guest, Wang Lei, global executive vice president and President of international business and China of AstraZeneca, pointed out in his speech that "the biggest impact on the whole pharmaceutical industry in 2020 is this new epidemic. The whole pharmaceutical industry has a significant impact on the entire human society, including a variety of vaccine related technology and therapeutic antibody technology, the speed of medical research and development. As a pharmaceutical enterprise, we feel unprecedented social responsibility. "

At the same time, the new epidemic also accelerated the rise of digital economy. "We see a number of new formats and models emerging and growing in the epidemic, including online consumption, unmanned distribution, internet medical care, and sharing formats, showing strong potential." Shen Ning, general manager of 3M's China Medical Products Division, said.

Zhang Ligang, founder and chairman of Aikang group, believes that the new epidemic has accelerated the application of new technologies such as artificial intelligence, gene detection and big data in the medical and health field, which will better enable the health examination industry and boost the development of health management from extensive development to fine development.

In addition to the impact of the epidemic, a new round of health care reform is also continuously releasing driving force, boosting the innovation and upgrading of China's medical and health industry.

Today, China's comprehensive capacity of pharmaceutical innovation has entered the second echelon of the world, with the emergence of heavy innovative drugs every year. However, in the past, China's biomedical industry was still dominated by generic drugs, more than 95% of which were generic drugs. In the view of Jiang Ningjun, chairman and CEO of cornerstone pharmaceutical, the nodes of fundamental changes in China's pharmaceutical industry will occur after 2015. He pointed out that three major events have taken place in China, which have led to key changes in the core of biomedical development: one is the continuous introduction of new policies by the pharmaceutical regulatory authorities; the second is a large amount of capital investment; and the third is the policy support for innovation.

At the policy level, such as the continuous promotion of the three medical (medical, medical and medical insurance) linkage reform in recent years, is involved in a wide range, causing widespread concern in all aspects. This time, Yu Baorong, member of the national DRG and dip expert group and professor of the University of foreign trade and economics, deeply analyzed the impact of DRG and dip medical insurance payment reform on the medical and pharmaceutical industry in the clinical process. As the largest medical consumption buyer in China, the reform of medical insurance payment mode has far-reaching influence. He believes that the behavior of hospitals or doctors can be affected by the changes of medical insurance payment methods, and then the sales of pharmaceutical products can be affected by the behaviors of hospitals and doctors. Finally, in order to improve the efficiency of medical services and the level of medical innovation, efficient use of limited medical insurance funds, forming a virtuous circle.

Two wheel drive of media and think tank

In order to better embrace the economic future of the big health industry, the 21st century economic report decided to further operate the big health content plate vertically and establish the 21st New Health Research Institute on the basis of integrating existing resources.

At the Yunfeng meeting, 21 new health research institute was officially established.

In the future, the new health section of the 21st century economic report will open up the media and think tank platforms, realize the dual drive of media communication and research think tanks, build a professional and high-quality platform in the field of big health with the big health industry summit as the basic platform, and the big health industry as the starting point, so as to realize the "health +" operation goals: Health + policy, health + capital, health + industry The media content of health + service and the ecological pattern of think tank product system.

At the meeting, 21 new Health Research Institute released the first research project results - "digital reading 2020 China's big health industry" series report: "2020 China's big health industry ten policy hot words", "2020 China's top ten development hot words of big health industry", as well as "2020 China's top 10 approved new drugs list" and "2021 world's top 10 most expected new drugs list".

In addition, the summit also released the "2020 China's big health industry list", and the results of seven series of awards were announced simultaneously.

"2021 China big health industry cloud Summit (spring)" is the first landing project of 2021 China's large health industry series activities. In the future, the 21st century economic report and 21st new health research institute will continue to focus on new policy changes and new industrial trends, and pay attention to the growth and development of industry leaders, figures and innovative enterprises. In the follow-up, a series of activities will be held, such as the seminar and exchange of industry regulatory policy experts, the evaluation of medical service products, the research on the competitiveness of biomedical parks, the offline visits and exchanges of enterprises in key industries, and the 2021 China Health Industry Summit and the 2021 "sunshine" award ceremony of China's health industry.